Rongce Zhao

1.8k total citations
36 papers, 401 citations indexed

About

Rongce Zhao is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Rongce Zhao has authored 36 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Hepatology. Recurrent topics in Rongce Zhao's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Rongce Zhao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Rongce Zhao collaborates with scholars based in China, United States and Hong Kong. Rongce Zhao's co-authors include Yang Qin, Yuan Huang, Jingyang He, Shaohua Li, Rong Guo, Zhong‐Jian Liu, Min Deng, Xiaoqin Yu, Qiuying Liu and Renguo Guan and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Rongce Zhao

34 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongce Zhao China 13 196 133 115 97 88 36 401
Weiqing Shao China 9 229 1.2× 152 1.1× 166 1.4× 91 0.9× 123 1.4× 20 503
Diyu Huang China 9 169 0.9× 136 1.0× 96 0.8× 86 0.9× 123 1.4× 27 466
Nguyen H. Tran United States 11 147 0.8× 249 1.9× 122 1.1× 88 0.9× 97 1.1× 59 470
Clelia Donisi Italy 7 152 0.8× 225 1.7× 102 0.9× 102 1.1× 34 0.4× 28 395
Anusha Thadi United States 6 116 0.6× 82 0.6× 62 0.5× 41 0.4× 60 0.7× 14 303
Yihua Huang China 12 161 0.8× 284 2.1× 94 0.8× 231 2.4× 57 0.6× 44 494
Haifeng Lin China 8 98 0.5× 108 0.8× 70 0.6× 55 0.6× 50 0.6× 32 303
Shima Mimura Japan 10 325 1.7× 146 1.1× 173 1.5× 40 0.4× 74 0.8× 41 495

Countries citing papers authored by Rongce Zhao

Since Specialization
Citations

This map shows the geographic impact of Rongce Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongce Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongce Zhao more than expected).

Fields of papers citing papers by Rongce Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongce Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongce Zhao. The network helps show where Rongce Zhao may publish in the future.

Co-authorship network of co-authors of Rongce Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Rongce Zhao. A scholar is included among the top collaborators of Rongce Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongce Zhao. Rongce Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Min, Rongce Zhao, Hao Zou, et al.. (2025). Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma. British Journal of Cancer. 132(4). 371–383. 2 indexed citations
2.
Guan, Renguo, Rongce Zhao, Jingwen Zou, et al.. (2025). Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma. Frontiers in Immunology. 15. 1496095–1496095. 2 indexed citations
3.
4.
5.
6.
7.
Li, Shaohua, Jie Mei, Rongce Zhao, et al.. (2024). Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma. Frontiers in Immunology. 15. 1491857–1491857. 2 indexed citations
8.
Zhao, Rongce, et al.. (2023). A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer. Frontiers in Pharmacology. 14. 1196158–1196158. 6 indexed citations
9.
Deng, Min, Rongce Zhao, Renguo Guan, et al.. (2023). Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy. European journal of medical research. 28(1). 328–328. 3 indexed citations
10.
Li, Shaohua, Jie Mei, Qiaoxuan Wang, et al.. (2023). Comparison of anti–PD-L1 with anti–PD-1 antibodies in the combination of HAIC and lenvatinib for the treatment of unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. 41(4_suppl). 509–509. 2 indexed citations
11.
Deng, Min, Rongce Zhao, Renguo Guan, et al.. (2022). The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Molecular Medicine. 28(1). 16–16. 57 indexed citations
12.
Wei, Ling, Qiuying Liu, Yuan Huang, et al.. (2020). Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 120. 105685–105685. 11 indexed citations
13.
Liu, Zhong‐Jian, Rongce Zhao, Yuan Huang, et al.. (2019). CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma. Acta Biochimica et Biophysica Sinica. 52(1). 18–25. 33 indexed citations
14.
Huang, Yuan, Ling Wei, Rongce Zhao, et al.. (2018). Predicting hepatocellular carcinoma development for cirrhosis patients via methylation detection of heparocarcinogenesis-related genes.. Journal of Cancer. 9(12). 2203–2210. 11 indexed citations
15.
Wei, Ling, Yuan Huang, Rongce Zhao, et al.. (2017). Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases. Clinical and Experimental Medicine. 18(1). 79–87. 30 indexed citations
16.
He, Jingyang, Yuan Huang, Zhong‐Jian Liu, et al.. (2017). Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma. Gene. 629. 29–34. 18 indexed citations
17.
Liu, Qiuying, Kefei Chen, Yuan Huang, et al.. (2017). BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells. Cancer Letters. 403. 165–174. 39 indexed citations
18.
Huang, Yuan, Ling Wei, Aimin Sun, et al.. (2016). [The Evaluation Value of Methylation Status of CpG Island of SFRP1 and LINE1 Gene Promoter Area in the Prognosis of Hepatocellular Carcinoma.]. PubMed. 47(6). 883–888. 3 indexed citations
19.
Zhou, Jing, Rongce Zhao, Feng Wen, et al.. (2016). Economic evaluation study (CHEER-compliant). Medicine. 95(27). e3762–e3762. 12 indexed citations
20.
Zhou, Jing, Rongce Zhao, Feng Wen, et al.. (2015). Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study. Medical Oncology. 32(4). 121–121. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiqing Shao Breakdown of academic impact, for papers by Diyu Huang Breakdown of academic impact, for papers by Nguyen H. Tran Breakdown of academic impact, for papers by Clelia Donisi Breakdown of academic impact, for papers by Anusha Thadi Breakdown of academic impact, for papers by Yihua Huang Breakdown of academic impact, for papers by Haifeng Lin Breakdown of academic impact, for papers by Shima Mimura
Rankless by CCL
2026